What's Happening?
The Centers for Disease Control and Prevention (CDC) has published a report indicating a significant rise in calls to U.S. poison centers regarding kratom exposure, with a 1,200% increase from 2015 to 2025. Kratom, a Southeast Asian botanical, is used
for pain relief and mood enhancement but has been linked to serious health outcomes, including 233 deaths over the past decade. The majority of these fatalities involved multiple substances, such as opioids and benzodiazepines. The report highlights the growing availability of high-potency kratom products in the U.S. and the associated risks, particularly when combined with other substances.
Why It's Important?
The surge in kratom-related incidents underscores the challenges in regulating and monitoring the use of alternative substances in the U.S. The increase in poison center calls and hospitalizations reflects the potential public health risks associated with unregulated kratom products. This situation highlights the need for more stringent oversight and public education on the dangers of combining kratom with other substances. The data also suggests a broader demographic uptake, indicating that kratom use is expanding beyond traditional user groups, which could lead to more widespread health implications.
What's Next?
The CDC recommends continued surveillance to identify high-risk patterns of kratom use, especially in multi-substance scenarios. Regulatory actions may focus on restricting products enriched with potent alkaloids like 7-hydroxymitragynine. Public health initiatives could aim to educate consumers and healthcare providers about the risks associated with kratom use. Poison centers remain a critical resource for real-time guidance and reporting adverse effects, playing a key role in surveillance and response efforts.
